These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10731882)

  • 1. [Therapy of venous thromboembolism with low-molecular-weight heparins].
    Haas S; Haas P; Creutzig A
    Vasa; 2000 Feb; 29(1):5-10. PubMed ID: 10731882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of thromboses with low-molecular-weight heparins].
    Haas S; Haas P
    Wien Med Wochenschr; 1999; 149(2-4):39-45; discussion 45. PubMed ID: 10378321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin: prophylaxis and treatment of venous thromboembolism.
    Pineo GF; Hull RD
    Annu Rev Med; 1997; 48():79-91. PubMed ID: 9046947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E
    Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
    Valiukiene L; Naudziūnas A; Unikauskas A
    Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular-weight heparin in the treatment of pulmonary embolism.
    Ageno W; Turpie AG
    Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of deep vein thrombosis with low-molecular-weight heparins: a consensus statement of the Gesellschaft für Thrombose-und Hämostaseforschung (GTH).
    Harenberg J; Schmitz-Huebner U; Breddin KH; Hass S; Heinrich F; Heinrichs C; Kienast J; Roebruck P; Theiss W; Wenzel E
    Semin Thromb Hemost; 1997; 23(1):91-6. PubMed ID: 9156416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of proximal deep venous thrombosis of the legs by low-molecular-weight heparin: a systematic review].
    Lamy O; Cornuz J; Yersin B
    Schweiz Med Wochenschr; 1999 May; 129(18):707-14. PubMed ID: 10407944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
    Cziraky MJ; Spinler SA
    Clin Pharm; 1993 Dec; 12(12):892-9. PubMed ID: 8137606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfractionated and low-molecular-weight heparin. Comparisons and current recommendations.
    Pineo GF; Hull RD
    Med Clin North Am; 1998 May; 82(3):587-99. PubMed ID: 9646781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient therapy with low-molecular-weight heparins: new perspectives for treatment of deep vein thrombosis.
    Büller HR
    Haemostasis; 1998; 28 Suppl 3():91-4. PubMed ID: 10069767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anticoagulation in patients with venous thromboembolism].
    Rüfer A; Wuillemin WA
    Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Strandness DE
    N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of low molecular weight heparin in total knee arthroplasty.
    Iobst CA; Friedman RJ
    Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.